Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

MBP1: a novel mutant p53-specific protein partner with oncogenic properties.

Gallagher WM, Argentini M, Sierra V, Bracco L, Debussche L, Conseiller E.

Oncogene. 1999 Jun 17;18(24):3608-16.

2.
3.
4.
5.

Different tumor-derived p53 mutants exhibit distinct biological activities.

Halevy O, Michalovitz D, Oren M.

Science. 1990 Oct 5;250(4977):113-6.

PMID:
2218501
6.

The p53 tumor suppressor gene and gene product.

Levine AJ.

Princess Takamatsu Symp. 1989;20:221-30. Review.

PMID:
2488233
7.

The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase.

Passer BJ, Nancy-Portebois V, Amzallag N, Prieur S, Cans C, Roborel de Climens A, Fiucci G, Bouvard V, Tuynder M, Susini L, Morchoisne S, Crible V, Lespagnol A, Dausset J, Oren M, Amson R, Telerman A.

Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2284-9. Epub 2003 Feb 26.

8.
9.

p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.

Campomenosi P, Monti P, Aprile A, Abbondandolo A, Frebourg T, Gold B, Crook T, Inga A, Resnick MA, Iggo R, Fronza G.

Oncogene. 2001 Jun 14;20(27):3573-9.

10.

Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights.

Merabet A, Houlleberghs H, Maclagan K, Akanho E, Bui TT, Pagano B, Drake AF, Fraternali F, Nikolova PV.

Biochem J. 2010 Mar 29;427(2):225-36. doi: 10.1042/BJ20091888.

PMID:
20113312
11.

Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation.

Rivlin N, Katz S, Doody M, Sheffer M, Horesh S, Molchadsky A, Koifman G, Shetzer Y, Goldfinger N, Rotter V, Geiger T.

Proc Natl Acad Sci U S A. 2014 May 13;111(19):7006-11. doi: 10.1073/pnas.1320428111. Epub 2014 Apr 28.

13.
14.

The Meq oncoprotein of Marek's disease virus interacts with p53 and inhibits its transcriptional and apoptotic activities.

Deng X, Li X, Shen Y, Qiu Y, Shi Z, Shao D, Jin Y, Chen H, Ding C, Li L, Chen P, Ma Z.

Virol J. 2010 Nov 26;7:348. doi: 10.1186/1743-422X-7-348.

15.
16.

The human 1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene.

Daniel-Carmi V, Makovitzki-Avraham E, Reuven EM, Goldstein I, Zilkha N, Rotter V, Tzehoval E, Eisenbach L.

Int J Cancer. 2009 Dec 15;125(12):2810-9. doi: 10.1002/ijc.24669.

17.
18.

A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.

Woitach JT, Zhang M, Niu CH, Thorgeirsson SS.

Nat Genet. 1998 Aug;19(4):371-4.

PMID:
9697699
19.

Interaction of oncogenic papillomavirus E6 proteins with fibulin-1.

Du M, Fan X, Hong E, Chen JJ.

Biochem Biophys Res Commun. 2002 Aug 30;296(4):962-9.

PMID:
12200142
20.

Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.

Suad O, Rozenberg H, Brosh R, Diskin-Posner Y, Kessler N, Shimon LJ, Frolow F, Liran A, Rotter V, Shakked Z.

J Mol Biol. 2009 Jan 9;385(1):249-65. doi: 10.1016/j.jmb.2008.10.063. Epub 2008 Oct 30.

PMID:
18996393

Supplemental Content

Support Center